Martingale Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-10,540
| Closed | -$262K | – | 920 |
|
|
2022
Q2 | $262K | Sell |
10,540
-5,794
| -35% | -$144K | ﹤0.01% | 764 |
|
|
2022
Q1 | $410K | Sell |
16,334
-1,300
| -7% | -$32.6K | 0.01% | 675 |
|
|
2021
Q4 | $643K | Sell |
17,634
-17,122
| -49% | -$624K | 0.01% | 585 |
|
|
2021
Q3 | $595K | Buy |
34,756
+4,000
| +13% | +$68.5K | 0.01% | 629 |
|
|
2021
Q2 | $412K | Buy |
+30,756
| New | +$412K | ﹤0.01% | 646 |
|